Amphotericin B lipid complex (ABLC)-associated hypertension: Case report and review

Clinical Infectious Diseases

Volumn 29, Issue 6, 1999, Pages 1564-1565

  Rowles, David M ^a   Fraser, Susan L ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG FORMULATION; HUMAN; HYPERTENSION; MALE; MYCOSIS; NEPHROTOXICITY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CHILD; DRUG COMBINATIONS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS;

EID: 0033396524     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313533     Document Type: Article

References (9)

1. 1. Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990; 12:308-29.
2. 2. Walsh TJ, Hiemenz JW, Seibel NL, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998; 26:1383-96.
3. 3. Garnacho-Montero J, Ortiz-Leyba C, Garmendina JLG, Jiménez FJJ. Life-threatening adverse event after amphotericin B lipid complex treatment in a patient treated previously with amphotericin B deoxycholate. Clin Infect Dis 1998; 26:1016.
4. 4. Dukes CS, Perfect JR. Amphotericin B-induced malignant hypertensive episodes [letter]. J Infect Dis 1990; 161:588.
5. 5. Omizo MKN, Bryant RE, Loveless MO. Amphotericin B-induced malignant hypertension [letter]. Clin Infect Dis 1993; 17:817-8.
6. 6. Katz BZ, Cohn RA. Amphotericin B and hypertension [letter]. Pediatr Infect Dis J 1994; 13:839-40.
7. 7. Le Y, Rana KZ, Dudley MN. Amphotericin B-associated hypertension. Ann Pharmacother 1996; 30:765-7.
8. 8. Ferreira E, Perreault MM. Hypertension exacerbated by amphotericin B administration [letter]. Ann Pharmacother 1997; 31:1407-8.
9. 9. Sawaya BP, Weihprecht H, Campbell WR, et al. Direct vasoconstriction as possible cause for amphotericin B-induced nephrotoxicity in rats. J Clin Invest 1991; 87:2097-107.